Company · CIK 0001662774 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Quince Therapeutics, Inc. · QNCX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 AForm 4 → | Jun 15, 5:57 pm EDT | David LamondDirector | 2,700 | — | — | 2,700 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:51 pm EDT | Christopher J. SennerDirector | 2,700 | — | — | 2,700 | — | |
| May 18, 2026 AForm 4 → | Jun 11, 5:30 pm EDT | Brigette RobertsChief Corp. Affairs Officer, Director | 16,698,162 | — | — | 6,837,319 | — | late |